- Issuer ticker
-
XBIT
- Reported as of
-
29 Aug 2025
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
3
- Accepted by SEC
-
30 Sep 2025, 09:21:47 UTC
Reporting owner
1 detail
- Reporting owner signature
-
Thomas Kuendig
Key filing fact
Thomas Martin Kuendig filed Form 3 for XBiotech Inc. (XBIT) on 30 Sep 2025.
Key facts
- This page summarizes Thomas Martin Kuendig's Form 3 filing for XBiotech Inc. (XBIT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 30 Sep 2025, 09:21.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reporting Owners (1)
CIK 0002088590
Primary reporting owner
Kuendig Thomas Martin
- Relationship
-
Director
- Address
- ALPENSTRASSE 23, 8803 RUESCHLIKON, KANTON OF ZUERICH, RUESCHLIKON, SWITZERLAND
- Signature
- Thomas Kuendig
- Signature date
- 29 Sep 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
XBIT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 200,000
- Date
- 29 Aug 2025
- Ownership
- Direct
XBIT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 50,000
- Date
- 29 Aug 2025
- Ownership
- By Daughter #1 - Stephanie Kuendig
XBIT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 50,000
- Date
- 29 Aug 2025
- Ownership
- By Daughter #2 - Michelle Kuendig
* marks a reported price that did not pass the local price check.